Trials / Sponsors / DelMar Pharmaceuticals, Inc.
DelMar Pharmaceuticals, Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer Ovarian Cancer | Phase 1 / Phase 2 | 2021-03-01 |
| Terminated | VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM Glioblastoma Multiforme, Glioblastoma, Glioma | Phase 3 | 2017-10-27 |